Immune Adjuvant Market - Global Outlook and Forecast 2022-2028
This report contains market size and forecasts of Immune Adjuvant in global, including the following market information:
Global Immune Adjuvant Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Immune Adjuvant Market Sales, 2017-2022, 2023-2028, (KG)
Global top five Immune Adjuvant companies in 2021 (%)
The global Immune Adjuvant market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Freund's Adjuvant Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Immune Adjuvant include SEPPIC, SDA BIO, Croda International Plc, SPI Pharma, Phibro Animal Health Corporation, Tj Kaiwei, Novavax, Zhuoyue and Aphios, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Immune Adjuvant manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Immune Adjuvant Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (KG)
Global Immune Adjuvant Market Segment Percentages, by Type, 2021 (%)
Global Immune Adjuvant Market Segment Percentages, by Application, 2021 (%)
Global Immune Adjuvant Market Segment Percentages, By Region and Country, 2021 (%)
The report also provides analysis of leading market participants including:
Key companies Immune Adjuvant revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Immune Adjuvant revenues share in global market, 2021 (%)
Key companies Immune Adjuvant sales in global market, 2017-2022 (Estimated), (KG)
Key companies Immune Adjuvant sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Global Immune Adjuvant Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Immune Adjuvant Market Sales, 2017-2022, 2023-2028, (KG)
Global top five Immune Adjuvant companies in 2021 (%)
The global Immune Adjuvant market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Freund's Adjuvant Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Immune Adjuvant include SEPPIC, SDA BIO, Croda International Plc, SPI Pharma, Phibro Animal Health Corporation, Tj Kaiwei, Novavax, Zhuoyue and Aphios, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Immune Adjuvant manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Immune Adjuvant Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (KG)
Global Immune Adjuvant Market Segment Percentages, by Type, 2021 (%)
- Freund's Adjuvant
- Cytokine Adjuvants
Global Immune Adjuvant Market Segment Percentages, by Application, 2021 (%)
- Research
- Commercial
Global Immune Adjuvant Market Segment Percentages, By Region and Country, 2021 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
The report also provides analysis of leading market participants including:
Key companies Immune Adjuvant revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Immune Adjuvant revenues share in global market, 2021 (%)
Key companies Immune Adjuvant sales in global market, 2017-2022 (Estimated), (KG)
Key companies Immune Adjuvant sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
- SEPPIC
- SDA BIO
- Croda International Plc
- SPI Pharma
- Phibro Animal Health Corporation
- Tj Kaiwei
- Novavax
- Zhuoyue
- Aphios
- GSK
- CSL Limited
- Brenntag Biosector
- Abace
- Avanti Polar Lipids
1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS
1.1 Immune Adjuvant Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Immune Adjuvant Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 GLOBAL IMMUNE ADJUVANT OVERALL MARKET SIZE
2.1 Global Immune Adjuvant Market Size: 2021 VS 2028
2.2 Global Immune Adjuvant Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Immune Adjuvant Sales: 2017-2028
3 COMPANY LANDSCAPE
3.1 Top Immune Adjuvant Players in Global Market
3.2 Top Global Immune Adjuvant Companies Ranked by Revenue
3.3 Global Immune Adjuvant Revenue by Companies
3.4 Global Immune Adjuvant Sales by Companies
3.5 Global Immune Adjuvant Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Immune Adjuvant Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Immune Adjuvant Product Type
3.8 Tier 1, Tier 2 and Tier 3 Immune Adjuvant Players in Global Market
3.8.1 List of Global Tier 1 Immune Adjuvant Companies
3.8.2 List of Global Tier 2 and Tier 3 Immune Adjuvant Companies
4 SIGHTS BY PRODUCT
4.1 Overview
4.1.1 By Type - Global Immune Adjuvant Market Size Markets, 2021 & 2028
4.1.2 Freund's Adjuvant
4.1.3 Cytokine Adjuvants
4.2 By Type - Global Immune Adjuvant Revenue & Forecasts
4.2.1 By Type - Global Immune Adjuvant Revenue, 2017-2022
4.2.2 By Type - Global Immune Adjuvant Revenue, 2023-2028
4.2.3 By Type - Global Immune Adjuvant Revenue Market Share, 2017-2028
4.3 By Type - Global Immune Adjuvant Sales & Forecasts
4.3.1 By Type - Global Immune Adjuvant Sales, 2017-2022
4.3.2 By Type - Global Immune Adjuvant Sales, 2023-2028
4.3.3 By Type - Global Immune Adjuvant Sales Market Share, 2017-2028
4.4 By Type - Global Immune Adjuvant Price (Manufacturers Selling Prices), 2017-2028
5 SIGHTS BY APPLICATION
5.1 Overview
5.1.1 By Application - Global Immune Adjuvant Market Size, 2021 & 2028
5.1.2 Research
5.1.3 Commercial
5.2 By Application - Global Immune Adjuvant Revenue & Forecasts
5.2.1 By Application - Global Immune Adjuvant Revenue, 2017-2022
5.2.2 By Application - Global Immune Adjuvant Revenue, 2023-2028
5.2.3 By Application - Global Immune Adjuvant Revenue Market Share, 2017-2028
5.3 By Application - Global Immune Adjuvant Sales & Forecasts
5.3.1 By Application - Global Immune Adjuvant Sales, 2017-2022
5.3.2 By Application - Global Immune Adjuvant Sales, 2023-2028
5.3.3 By Application - Global Immune Adjuvant Sales Market Share, 2017-2028
5.4 By Application - Global Immune Adjuvant Price (Manufacturers Selling Prices), 2017-2028
6 SIGHTS BY REGION
6.1 By Region - Global Immune Adjuvant Market Size, 2021 & 2028
6.2 By Region - Global Immune Adjuvant Revenue & Forecasts
6.2.1 By Region - Global Immune Adjuvant Revenue, 2017-2022
6.2.2 By Region - Global Immune Adjuvant Revenue, 2023-2028
6.2.3 By Region - Global Immune Adjuvant Revenue Market Share, 2017-2028
6.3 By Region - Global Immune Adjuvant Sales & Forecasts
6.3.1 By Region - Global Immune Adjuvant Sales, 2017-2022
6.3.2 By Region - Global Immune Adjuvant Sales, 2023-2028
6.3.3 By Region - Global Immune Adjuvant Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country - North America Immune Adjuvant Revenue, 2017-2028
6.4.2 By Country - North America Immune Adjuvant Sales, 2017-2028
6.4.3 US Immune Adjuvant Market Size, 2017-2028
6.4.4 Canada Immune Adjuvant Market Size, 2017-2028
6.4.5 Mexico Immune Adjuvant Market Size, 2017-2028
6.5 Europe
6.5.1 By Country - Europe Immune Adjuvant Revenue, 2017-2028
6.5.2 By Country - Europe Immune Adjuvant Sales, 2017-2028
6.5.3 Germany Immune Adjuvant Market Size, 2017-2028
6.5.4 France Immune Adjuvant Market Size, 2017-2028
6.5.5 U.K. Immune Adjuvant Market Size, 2017-2028
6.5.6 Italy Immune Adjuvant Market Size, 2017-2028
6.5.7 Russia Immune Adjuvant Market Size, 2017-2028
6.5.8 Nordic Countries Immune Adjuvant Market Size, 2017-2028
6.5.9 Benelux Immune Adjuvant Market Size, 2017-2028
6.6 Asia
6.6.1 By Region - Asia Immune Adjuvant Revenue, 2017-2028
6.6.2 By Region - Asia Immune Adjuvant Sales, 2017-2028
6.6.3 China Immune Adjuvant Market Size, 2017-2028
6.6.4 Japan Immune Adjuvant Market Size, 2017-2028
6.6.5 South Korea Immune Adjuvant Market Size, 2017-2028
6.6.6 Southeast Asia Immune Adjuvant Market Size, 2017-2028
6.6.7 India Immune Adjuvant Market Size, 2017-2028
6.7 South America
6.7.1 By Country - South America Immune Adjuvant Revenue, 2017-2028
6.7.2 By Country - South America Immune Adjuvant Sales, 2017-2028
6.7.3 Brazil Immune Adjuvant Market Size, 2017-2028
6.7.4 Argentina Immune Adjuvant Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Immune Adjuvant Revenue, 2017-2028
6.8.2 By Country - Middle East & Africa Immune Adjuvant Sales, 2017-2028
6.8.3 Turkey Immune Adjuvant Market Size, 2017-2028
6.8.4 Israel Immune Adjuvant Market Size, 2017-2028
6.8.5 Saudi Arabia Immune Adjuvant Market Size, 2017-2028
6.8.6 UAE Immune Adjuvant Market Size, 2017-2028
7 MANUFACTURERS & BRANDS PROFILES
7.1 SEPPIC
7.1.1 SEPPIC Corporate Summary
7.1.2 SEPPIC Business Overview
7.1.3 SEPPIC Immune Adjuvant Major Product Offerings
7.1.4 SEPPIC Immune Adjuvant Sales and Revenue in Global (2017-2022)
7.1.5 SEPPIC Key News
7.2 SDA BIO
7.2.1 SDA BIO Corporate Summary
7.2.2 SDA BIO Business Overview
7.2.3 SDA BIO Immune Adjuvant Major Product Offerings
7.2.4 SDA BIO Immune Adjuvant Sales and Revenue in Global (2017-2022)
7.2.5 SDA BIO Key News
7.3 Croda International Plc
7.3.1 Croda International Plc Corporate Summary
7.3.2 Croda International Plc Business Overview
7.3.3 Croda International Plc Immune Adjuvant Major Product Offerings
7.3.4 Croda International Plc Immune Adjuvant Sales and Revenue in Global (2017-2022)
7.3.5 Croda International Plc Key News
7.4 SPI Pharma
7.4.1 SPI Pharma Corporate Summary
7.4.2 SPI Pharma Business Overview
7.4.3 SPI Pharma Immune Adjuvant Major Product Offerings
7.4.4 SPI Pharma Immune Adjuvant Sales and Revenue in Global (2017-2022)
7.4.5 SPI Pharma Key News
7.5 Phibro Animal Health Corporation
7.5.1 Phibro Animal Health Corporation Corporate Summary
7.5.2 Phibro Animal Health Corporation Business Overview
7.5.3 Phibro Animal Health Corporation Immune Adjuvant Major Product Offerings
7.5.4 Phibro Animal Health Corporation Immune Adjuvant Sales and Revenue in Global (2017-2022)
7.5.5 Phibro Animal Health Corporation Key News
7.6 Tj Kaiwei
7.6.1 Tj Kaiwei Corporate Summary
7.6.2 Tj Kaiwei Business Overview
7.6.3 Tj Kaiwei Immune Adjuvant Major Product Offerings
7.6.4 Tj Kaiwei Immune Adjuvant Sales and Revenue in Global (2017-2022)
7.6.5 Tj Kaiwei Key News
7.7 Novavax
7.7.1 Novavax Corporate Summary
7.7.2 Novavax Business Overview
7.7.3 Novavax Immune Adjuvant Major Product Offerings
7.7.4 Novavax Immune Adjuvant Sales and Revenue in Global (2017-2022)
7.7.5 Novavax Key News
7.8 Zhuoyue
7.8.1 Zhuoyue Corporate Summary
7.8.2 Zhuoyue Business Overview
7.8.3 Zhuoyue Immune Adjuvant Major Product Offerings
7.8.4 Zhuoyue Immune Adjuvant Sales and Revenue in Global (2017-2022)
7.8.5 Zhuoyue Key News
7.9 Aphios
7.9.1 Aphios Corporate Summary
7.9.2 Aphios Business Overview
7.9.3 Aphios Immune Adjuvant Major Product Offerings
7.9.4 Aphios Immune Adjuvant Sales and Revenue in Global (2017-2022)
7.9.5 Aphios Key News
7.10 GSK
7.10.1 GSK Corporate Summary
7.10.2 GSK Business Overview
7.10.3 GSK Immune Adjuvant Major Product Offerings
7.10.4 GSK Immune Adjuvant Sales and Revenue in Global (2017-2022)
7.10.5 GSK Key News
7.11 CSL Limited
7.11.1 CSL Limited Corporate Summary
7.11.2 CSL Limited Immune Adjuvant Business Overview
7.11.3 CSL Limited Immune Adjuvant Major Product Offerings
7.11.4 CSL Limited Immune Adjuvant Sales and Revenue in Global (2017-2022)
7.11.5 CSL Limited Key News
7.12 Brenntag Biosector
7.12.1 Brenntag Biosector Corporate Summary
7.12.2 Brenntag Biosector Immune Adjuvant Business Overview
7.12.3 Brenntag Biosector Immune Adjuvant Major Product Offerings
7.12.4 Brenntag Biosector Immune Adjuvant Sales and Revenue in Global (2017-2022)
7.12.5 Brenntag Biosector Key News
7.13 Abace
7.13.1 Abace Corporate Summary
7.13.2 Abace Immune Adjuvant Business Overview
7.13.3 Abace Immune Adjuvant Major Product Offerings
7.13.4 Abace Immune Adjuvant Sales and Revenue in Global (2017-2022)
7.13.5 Abace Key News
7.14 Avanti Polar Lipids
7.14.1 Avanti Polar Lipids Corporate Summary
7.14.2 Avanti Polar Lipids Business Overview
7.14.3 Avanti Polar Lipids Immune Adjuvant Major Product Offerings
7.14.4 Avanti Polar Lipids Immune Adjuvant Sales and Revenue in Global (2017-2022)
7.14.5 Avanti Polar Lipids Key News
8 GLOBAL IMMUNE ADJUVANT PRODUCTION CAPACITY, ANALYSIS
8.1 Global Immune Adjuvant Production Capacity, 2017-2028
8.2 Immune Adjuvant Production Capacity of Key Manufacturers in Global Market
8.3 Global Immune Adjuvant Production by Region
9 KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 IMMUNE ADJUVANT SUPPLY CHAIN ANALYSIS
10.1 Immune Adjuvant Industry Value Chain
10.2 Immune Adjuvant Upstream Market
10.3 Immune Adjuvant Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Immune Adjuvant Distributors and Sales Agents in Global
11 CONCLUSION
12 APPENDIX
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
1.1 Immune Adjuvant Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Immune Adjuvant Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 GLOBAL IMMUNE ADJUVANT OVERALL MARKET SIZE
2.1 Global Immune Adjuvant Market Size: 2021 VS 2028
2.2 Global Immune Adjuvant Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Immune Adjuvant Sales: 2017-2028
3 COMPANY LANDSCAPE
3.1 Top Immune Adjuvant Players in Global Market
3.2 Top Global Immune Adjuvant Companies Ranked by Revenue
3.3 Global Immune Adjuvant Revenue by Companies
3.4 Global Immune Adjuvant Sales by Companies
3.5 Global Immune Adjuvant Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Immune Adjuvant Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Immune Adjuvant Product Type
3.8 Tier 1, Tier 2 and Tier 3 Immune Adjuvant Players in Global Market
3.8.1 List of Global Tier 1 Immune Adjuvant Companies
3.8.2 List of Global Tier 2 and Tier 3 Immune Adjuvant Companies
4 SIGHTS BY PRODUCT
4.1 Overview
4.1.1 By Type - Global Immune Adjuvant Market Size Markets, 2021 & 2028
4.1.2 Freund's Adjuvant
4.1.3 Cytokine Adjuvants
4.2 By Type - Global Immune Adjuvant Revenue & Forecasts
4.2.1 By Type - Global Immune Adjuvant Revenue, 2017-2022
4.2.2 By Type - Global Immune Adjuvant Revenue, 2023-2028
4.2.3 By Type - Global Immune Adjuvant Revenue Market Share, 2017-2028
4.3 By Type - Global Immune Adjuvant Sales & Forecasts
4.3.1 By Type - Global Immune Adjuvant Sales, 2017-2022
4.3.2 By Type - Global Immune Adjuvant Sales, 2023-2028
4.3.3 By Type - Global Immune Adjuvant Sales Market Share, 2017-2028
4.4 By Type - Global Immune Adjuvant Price (Manufacturers Selling Prices), 2017-2028
5 SIGHTS BY APPLICATION
5.1 Overview
5.1.1 By Application - Global Immune Adjuvant Market Size, 2021 & 2028
5.1.2 Research
5.1.3 Commercial
5.2 By Application - Global Immune Adjuvant Revenue & Forecasts
5.2.1 By Application - Global Immune Adjuvant Revenue, 2017-2022
5.2.2 By Application - Global Immune Adjuvant Revenue, 2023-2028
5.2.3 By Application - Global Immune Adjuvant Revenue Market Share, 2017-2028
5.3 By Application - Global Immune Adjuvant Sales & Forecasts
5.3.1 By Application - Global Immune Adjuvant Sales, 2017-2022
5.3.2 By Application - Global Immune Adjuvant Sales, 2023-2028
5.3.3 By Application - Global Immune Adjuvant Sales Market Share, 2017-2028
5.4 By Application - Global Immune Adjuvant Price (Manufacturers Selling Prices), 2017-2028
6 SIGHTS BY REGION
6.1 By Region - Global Immune Adjuvant Market Size, 2021 & 2028
6.2 By Region - Global Immune Adjuvant Revenue & Forecasts
6.2.1 By Region - Global Immune Adjuvant Revenue, 2017-2022
6.2.2 By Region - Global Immune Adjuvant Revenue, 2023-2028
6.2.3 By Region - Global Immune Adjuvant Revenue Market Share, 2017-2028
6.3 By Region - Global Immune Adjuvant Sales & Forecasts
6.3.1 By Region - Global Immune Adjuvant Sales, 2017-2022
6.3.2 By Region - Global Immune Adjuvant Sales, 2023-2028
6.3.3 By Region - Global Immune Adjuvant Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country - North America Immune Adjuvant Revenue, 2017-2028
6.4.2 By Country - North America Immune Adjuvant Sales, 2017-2028
6.4.3 US Immune Adjuvant Market Size, 2017-2028
6.4.4 Canada Immune Adjuvant Market Size, 2017-2028
6.4.5 Mexico Immune Adjuvant Market Size, 2017-2028
6.5 Europe
6.5.1 By Country - Europe Immune Adjuvant Revenue, 2017-2028
6.5.2 By Country - Europe Immune Adjuvant Sales, 2017-2028
6.5.3 Germany Immune Adjuvant Market Size, 2017-2028
6.5.4 France Immune Adjuvant Market Size, 2017-2028
6.5.5 U.K. Immune Adjuvant Market Size, 2017-2028
6.5.6 Italy Immune Adjuvant Market Size, 2017-2028
6.5.7 Russia Immune Adjuvant Market Size, 2017-2028
6.5.8 Nordic Countries Immune Adjuvant Market Size, 2017-2028
6.5.9 Benelux Immune Adjuvant Market Size, 2017-2028
6.6 Asia
6.6.1 By Region - Asia Immune Adjuvant Revenue, 2017-2028
6.6.2 By Region - Asia Immune Adjuvant Sales, 2017-2028
6.6.3 China Immune Adjuvant Market Size, 2017-2028
6.6.4 Japan Immune Adjuvant Market Size, 2017-2028
6.6.5 South Korea Immune Adjuvant Market Size, 2017-2028
6.6.6 Southeast Asia Immune Adjuvant Market Size, 2017-2028
6.6.7 India Immune Adjuvant Market Size, 2017-2028
6.7 South America
6.7.1 By Country - South America Immune Adjuvant Revenue, 2017-2028
6.7.2 By Country - South America Immune Adjuvant Sales, 2017-2028
6.7.3 Brazil Immune Adjuvant Market Size, 2017-2028
6.7.4 Argentina Immune Adjuvant Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Immune Adjuvant Revenue, 2017-2028
6.8.2 By Country - Middle East & Africa Immune Adjuvant Sales, 2017-2028
6.8.3 Turkey Immune Adjuvant Market Size, 2017-2028
6.8.4 Israel Immune Adjuvant Market Size, 2017-2028
6.8.5 Saudi Arabia Immune Adjuvant Market Size, 2017-2028
6.8.6 UAE Immune Adjuvant Market Size, 2017-2028
7 MANUFACTURERS & BRANDS PROFILES
7.1 SEPPIC
7.1.1 SEPPIC Corporate Summary
7.1.2 SEPPIC Business Overview
7.1.3 SEPPIC Immune Adjuvant Major Product Offerings
7.1.4 SEPPIC Immune Adjuvant Sales and Revenue in Global (2017-2022)
7.1.5 SEPPIC Key News
7.2 SDA BIO
7.2.1 SDA BIO Corporate Summary
7.2.2 SDA BIO Business Overview
7.2.3 SDA BIO Immune Adjuvant Major Product Offerings
7.2.4 SDA BIO Immune Adjuvant Sales and Revenue in Global (2017-2022)
7.2.5 SDA BIO Key News
7.3 Croda International Plc
7.3.1 Croda International Plc Corporate Summary
7.3.2 Croda International Plc Business Overview
7.3.3 Croda International Plc Immune Adjuvant Major Product Offerings
7.3.4 Croda International Plc Immune Adjuvant Sales and Revenue in Global (2017-2022)
7.3.5 Croda International Plc Key News
7.4 SPI Pharma
7.4.1 SPI Pharma Corporate Summary
7.4.2 SPI Pharma Business Overview
7.4.3 SPI Pharma Immune Adjuvant Major Product Offerings
7.4.4 SPI Pharma Immune Adjuvant Sales and Revenue in Global (2017-2022)
7.4.5 SPI Pharma Key News
7.5 Phibro Animal Health Corporation
7.5.1 Phibro Animal Health Corporation Corporate Summary
7.5.2 Phibro Animal Health Corporation Business Overview
7.5.3 Phibro Animal Health Corporation Immune Adjuvant Major Product Offerings
7.5.4 Phibro Animal Health Corporation Immune Adjuvant Sales and Revenue in Global (2017-2022)
7.5.5 Phibro Animal Health Corporation Key News
7.6 Tj Kaiwei
7.6.1 Tj Kaiwei Corporate Summary
7.6.2 Tj Kaiwei Business Overview
7.6.3 Tj Kaiwei Immune Adjuvant Major Product Offerings
7.6.4 Tj Kaiwei Immune Adjuvant Sales and Revenue in Global (2017-2022)
7.6.5 Tj Kaiwei Key News
7.7 Novavax
7.7.1 Novavax Corporate Summary
7.7.2 Novavax Business Overview
7.7.3 Novavax Immune Adjuvant Major Product Offerings
7.7.4 Novavax Immune Adjuvant Sales and Revenue in Global (2017-2022)
7.7.5 Novavax Key News
7.8 Zhuoyue
7.8.1 Zhuoyue Corporate Summary
7.8.2 Zhuoyue Business Overview
7.8.3 Zhuoyue Immune Adjuvant Major Product Offerings
7.8.4 Zhuoyue Immune Adjuvant Sales and Revenue in Global (2017-2022)
7.8.5 Zhuoyue Key News
7.9 Aphios
7.9.1 Aphios Corporate Summary
7.9.2 Aphios Business Overview
7.9.3 Aphios Immune Adjuvant Major Product Offerings
7.9.4 Aphios Immune Adjuvant Sales and Revenue in Global (2017-2022)
7.9.5 Aphios Key News
7.10 GSK
7.10.1 GSK Corporate Summary
7.10.2 GSK Business Overview
7.10.3 GSK Immune Adjuvant Major Product Offerings
7.10.4 GSK Immune Adjuvant Sales and Revenue in Global (2017-2022)
7.10.5 GSK Key News
7.11 CSL Limited
7.11.1 CSL Limited Corporate Summary
7.11.2 CSL Limited Immune Adjuvant Business Overview
7.11.3 CSL Limited Immune Adjuvant Major Product Offerings
7.11.4 CSL Limited Immune Adjuvant Sales and Revenue in Global (2017-2022)
7.11.5 CSL Limited Key News
7.12 Brenntag Biosector
7.12.1 Brenntag Biosector Corporate Summary
7.12.2 Brenntag Biosector Immune Adjuvant Business Overview
7.12.3 Brenntag Biosector Immune Adjuvant Major Product Offerings
7.12.4 Brenntag Biosector Immune Adjuvant Sales and Revenue in Global (2017-2022)
7.12.5 Brenntag Biosector Key News
7.13 Abace
7.13.1 Abace Corporate Summary
7.13.2 Abace Immune Adjuvant Business Overview
7.13.3 Abace Immune Adjuvant Major Product Offerings
7.13.4 Abace Immune Adjuvant Sales and Revenue in Global (2017-2022)
7.13.5 Abace Key News
7.14 Avanti Polar Lipids
7.14.1 Avanti Polar Lipids Corporate Summary
7.14.2 Avanti Polar Lipids Business Overview
7.14.3 Avanti Polar Lipids Immune Adjuvant Major Product Offerings
7.14.4 Avanti Polar Lipids Immune Adjuvant Sales and Revenue in Global (2017-2022)
7.14.5 Avanti Polar Lipids Key News
8 GLOBAL IMMUNE ADJUVANT PRODUCTION CAPACITY, ANALYSIS
8.1 Global Immune Adjuvant Production Capacity, 2017-2028
8.2 Immune Adjuvant Production Capacity of Key Manufacturers in Global Market
8.3 Global Immune Adjuvant Production by Region
9 KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 IMMUNE ADJUVANT SUPPLY CHAIN ANALYSIS
10.1 Immune Adjuvant Industry Value Chain
10.2 Immune Adjuvant Upstream Market
10.3 Immune Adjuvant Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Immune Adjuvant Distributors and Sales Agents in Global
11 CONCLUSION
12 APPENDIX
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES
Table 1. Key Players of Immune Adjuvant in Global Market
Table 2. Top Immune Adjuvant Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Immune Adjuvant Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Immune Adjuvant Revenue Share by Companies, 2017-2022
Table 5. Global Immune Adjuvant Sales by Companies, (KG), 2017-2022
Table 6. Global Immune Adjuvant Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Immune Adjuvant Price (2017-2022) & (US$/KG)
Table 8. Global Manufacturers Immune Adjuvant Product Type
Table 9. List of Global Tier 1 Immune Adjuvant Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Immune Adjuvant Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Immune Adjuvant Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global Immune Adjuvant Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global Immune Adjuvant Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global Immune Adjuvant Sales (KG), 2017-2022
Table 15. By Type - Global Immune Adjuvant Sales (KG), 2023-2028
Table 16. By Application – Global Immune Adjuvant Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global Immune Adjuvant Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global Immune Adjuvant Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global Immune Adjuvant Sales (KG), 2017-2022
Table 20. By Application - Global Immune Adjuvant Sales (KG), 2023-2028
Table 21. By Region – Global Immune Adjuvant Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Immune Adjuvant Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Immune Adjuvant Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Immune Adjuvant Sales (KG), 2017-2022
Table 25. By Region - Global Immune Adjuvant Sales (KG), 2023-2028
Table 26. By Country - North America Immune Adjuvant Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Immune Adjuvant Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Immune Adjuvant Sales, (KG), 2017-2022
Table 29. By Country - North America Immune Adjuvant Sales, (KG), 2023-2028
Table 30. By Country - Europe Immune Adjuvant Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Immune Adjuvant Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Immune Adjuvant Sales, (KG), 2017-2022
Table 33. By Country - Europe Immune Adjuvant Sales, (KG), 2023-2028
Table 34. By Region - Asia Immune Adjuvant Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Immune Adjuvant Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Immune Adjuvant Sales, (KG), 2017-2022
Table 37. By Region - Asia Immune Adjuvant Sales, (KG), 2023-2028
Table 38. By Country - South America Immune Adjuvant Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Immune Adjuvant Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Immune Adjuvant Sales, (KG), 2017-2022
Table 41. By Country - South America Immune Adjuvant Sales, (KG), 2023-2028
Table 42. By Country - Middle East & Africa Immune Adjuvant Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Immune Adjuvant Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Immune Adjuvant Sales, (KG), 2017-2022
Table 45. By Country - Middle East & Africa Immune Adjuvant Sales, (KG), 2023-2028
Table 46. SEPPIC Corporate Summary
Table 47. SEPPIC Immune Adjuvant Product Offerings
Table 48. SEPPIC Immune Adjuvant Sales (KG), Revenue (US$, Mn) and Average Price (US$/KG) (2017-2022)
Table 49. SDA BIO Corporate Summary
Table 50. SDA BIO Immune Adjuvant Product Offerings
Table 51. SDA BIO Immune Adjuvant Sales (KG), Revenue (US$, Mn) and Average Price (US$/KG) (2017-2022)
Table 52. Croda International Plc Corporate Summary
Table 53. Croda International Plc Immune Adjuvant Product Offerings
Table 54. Croda International Plc Immune Adjuvant Sales (KG), Revenue (US$, Mn) and Average Price (US$/KG) (2017-2022)
Table 55. SPI Pharma Corporate Summary
Table 56. SPI Pharma Immune Adjuvant Product Offerings
Table 57. SPI Pharma Immune Adjuvant Sales (KG), Revenue (US$, Mn) and Average Price (US$/KG) (2017-2022)
Table 58. Phibro Animal Health Corporation Corporate Summary
Table 59. Phibro Animal Health Corporation Immune Adjuvant Product Offerings
Table 60. Phibro Animal Health Corporation Immune Adjuvant Sales (KG), Revenue (US$, Mn) and Average Price (US$/KG) (2017-2022)
Table 61. Tj Kaiwei Corporate Summary
Table 62. Tj Kaiwei Immune Adjuvant Product Offerings
Table 63. Tj Kaiwei Immune Adjuvant Sales (KG), Revenue (US$, Mn) and Average Price (US$/KG) (2017-2022)
Table 64. Novavax Corporate Summary
Table 65. Novavax Immune Adjuvant Product Offerings
Table 66. Novavax Immune Adjuvant Sales (KG), Revenue (US$, Mn) and Average Price (US$/KG) (2017-2022)
Table 67. Zhuoyue Corporate Summary
Table 68. Zhuoyue Immune Adjuvant Product Offerings
Table 69. Zhuoyue Immune Adjuvant Sales (KG), Revenue (US$, Mn) and Average Price (US$/KG) (2017-2022)
Table 70. Aphios Corporate Summary
Table 71. Aphios Immune Adjuvant Product Offerings
Table 72. Aphios Immune Adjuvant Sales (KG), Revenue (US$, Mn) and Average Price (US$/KG) (2017-2022)
Table 73. GSK Corporate Summary
Table 74. GSK Immune Adjuvant Product Offerings
Table 75. GSK Immune Adjuvant Sales (KG), Revenue (US$, Mn) and Average Price (US$/KG) (2017-2022)
Table 76. CSL Limited Corporate Summary
Table 77. CSL Limited Immune Adjuvant Product Offerings
Table 78. CSL Limited Immune Adjuvant Sales (KG), Revenue (US$, Mn) and Average Price (US$/KG) (2017-2022)
Table 79. Brenntag Biosector Corporate Summary
Table 80. Brenntag Biosector Immune Adjuvant Product Offerings
Table 81. Brenntag Biosector Immune Adjuvant Sales (KG), Revenue (US$, Mn) and Average Price (US$/KG) (2017-2022)
Table 82. Abace Corporate Summary
Table 83. Abace Immune Adjuvant Product Offerings
Table 84. Abace Immune Adjuvant Sales (KG), Revenue (US$, Mn) and Average Price (US$/KG) (2017-2022)
Table 85. Avanti Polar Lipids Corporate Summary
Table 86. Avanti Polar Lipids Immune Adjuvant Product Offerings
Table 87. Avanti Polar Lipids Immune Adjuvant Sales (KG), Revenue (US$, Mn) and Average Price (US$/KG) (2017-2022)
Table 88. Immune Adjuvant Production Capacity (KG) of Key Manufacturers in Global Market, 2020-2022 (KG)
Table 89. Global Immune Adjuvant Capacity Market Share of Key Manufacturers, 2020-2022
Table 90. Global Immune Adjuvant Production by Region, 2017-2022 (KG)
Table 91. Global Immune Adjuvant Production by Region, 2023-2028 (KG)
Table 92. Immune Adjuvant Market Opportunities & Trends in Global Market
Table 93. Immune Adjuvant Market Drivers in Global Market
Table 94. Immune Adjuvant Market Restraints in Global Market
Table 95. Immune Adjuvant Raw Materials
Table 96. Immune Adjuvant Raw Materials Suppliers in Global Market
Table 97. Typical Immune Adjuvant Downstream
Table 98. Immune Adjuvant Downstream Clients in Global Market
Table 99. Immune Adjuvant Distributors and Sales Agents in Global Market
Table 1. Key Players of Immune Adjuvant in Global Market
Table 2. Top Immune Adjuvant Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Immune Adjuvant Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Immune Adjuvant Revenue Share by Companies, 2017-2022
Table 5. Global Immune Adjuvant Sales by Companies, (KG), 2017-2022
Table 6. Global Immune Adjuvant Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Immune Adjuvant Price (2017-2022) & (US$/KG)
Table 8. Global Manufacturers Immune Adjuvant Product Type
Table 9. List of Global Tier 1 Immune Adjuvant Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Immune Adjuvant Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Immune Adjuvant Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global Immune Adjuvant Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global Immune Adjuvant Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global Immune Adjuvant Sales (KG), 2017-2022
Table 15. By Type - Global Immune Adjuvant Sales (KG), 2023-2028
Table 16. By Application – Global Immune Adjuvant Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global Immune Adjuvant Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global Immune Adjuvant Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global Immune Adjuvant Sales (KG), 2017-2022
Table 20. By Application - Global Immune Adjuvant Sales (KG), 2023-2028
Table 21. By Region – Global Immune Adjuvant Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Immune Adjuvant Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Immune Adjuvant Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Immune Adjuvant Sales (KG), 2017-2022
Table 25. By Region - Global Immune Adjuvant Sales (KG), 2023-2028
Table 26. By Country - North America Immune Adjuvant Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Immune Adjuvant Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Immune Adjuvant Sales, (KG), 2017-2022
Table 29. By Country - North America Immune Adjuvant Sales, (KG), 2023-2028
Table 30. By Country - Europe Immune Adjuvant Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Immune Adjuvant Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Immune Adjuvant Sales, (KG), 2017-2022
Table 33. By Country - Europe Immune Adjuvant Sales, (KG), 2023-2028
Table 34. By Region - Asia Immune Adjuvant Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Immune Adjuvant Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Immune Adjuvant Sales, (KG), 2017-2022
Table 37. By Region - Asia Immune Adjuvant Sales, (KG), 2023-2028
Table 38. By Country - South America Immune Adjuvant Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Immune Adjuvant Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Immune Adjuvant Sales, (KG), 2017-2022
Table 41. By Country - South America Immune Adjuvant Sales, (KG), 2023-2028
Table 42. By Country - Middle East & Africa Immune Adjuvant Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Immune Adjuvant Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Immune Adjuvant Sales, (KG), 2017-2022
Table 45. By Country - Middle East & Africa Immune Adjuvant Sales, (KG), 2023-2028
Table 46. SEPPIC Corporate Summary
Table 47. SEPPIC Immune Adjuvant Product Offerings
Table 48. SEPPIC Immune Adjuvant Sales (KG), Revenue (US$, Mn) and Average Price (US$/KG) (2017-2022)
Table 49. SDA BIO Corporate Summary
Table 50. SDA BIO Immune Adjuvant Product Offerings
Table 51. SDA BIO Immune Adjuvant Sales (KG), Revenue (US$, Mn) and Average Price (US$/KG) (2017-2022)
Table 52. Croda International Plc Corporate Summary
Table 53. Croda International Plc Immune Adjuvant Product Offerings
Table 54. Croda International Plc Immune Adjuvant Sales (KG), Revenue (US$, Mn) and Average Price (US$/KG) (2017-2022)
Table 55. SPI Pharma Corporate Summary
Table 56. SPI Pharma Immune Adjuvant Product Offerings
Table 57. SPI Pharma Immune Adjuvant Sales (KG), Revenue (US$, Mn) and Average Price (US$/KG) (2017-2022)
Table 58. Phibro Animal Health Corporation Corporate Summary
Table 59. Phibro Animal Health Corporation Immune Adjuvant Product Offerings
Table 60. Phibro Animal Health Corporation Immune Adjuvant Sales (KG), Revenue (US$, Mn) and Average Price (US$/KG) (2017-2022)
Table 61. Tj Kaiwei Corporate Summary
Table 62. Tj Kaiwei Immune Adjuvant Product Offerings
Table 63. Tj Kaiwei Immune Adjuvant Sales (KG), Revenue (US$, Mn) and Average Price (US$/KG) (2017-2022)
Table 64. Novavax Corporate Summary
Table 65. Novavax Immune Adjuvant Product Offerings
Table 66. Novavax Immune Adjuvant Sales (KG), Revenue (US$, Mn) and Average Price (US$/KG) (2017-2022)
Table 67. Zhuoyue Corporate Summary
Table 68. Zhuoyue Immune Adjuvant Product Offerings
Table 69. Zhuoyue Immune Adjuvant Sales (KG), Revenue (US$, Mn) and Average Price (US$/KG) (2017-2022)
Table 70. Aphios Corporate Summary
Table 71. Aphios Immune Adjuvant Product Offerings
Table 72. Aphios Immune Adjuvant Sales (KG), Revenue (US$, Mn) and Average Price (US$/KG) (2017-2022)
Table 73. GSK Corporate Summary
Table 74. GSK Immune Adjuvant Product Offerings
Table 75. GSK Immune Adjuvant Sales (KG), Revenue (US$, Mn) and Average Price (US$/KG) (2017-2022)
Table 76. CSL Limited Corporate Summary
Table 77. CSL Limited Immune Adjuvant Product Offerings
Table 78. CSL Limited Immune Adjuvant Sales (KG), Revenue (US$, Mn) and Average Price (US$/KG) (2017-2022)
Table 79. Brenntag Biosector Corporate Summary
Table 80. Brenntag Biosector Immune Adjuvant Product Offerings
Table 81. Brenntag Biosector Immune Adjuvant Sales (KG), Revenue (US$, Mn) and Average Price (US$/KG) (2017-2022)
Table 82. Abace Corporate Summary
Table 83. Abace Immune Adjuvant Product Offerings
Table 84. Abace Immune Adjuvant Sales (KG), Revenue (US$, Mn) and Average Price (US$/KG) (2017-2022)
Table 85. Avanti Polar Lipids Corporate Summary
Table 86. Avanti Polar Lipids Immune Adjuvant Product Offerings
Table 87. Avanti Polar Lipids Immune Adjuvant Sales (KG), Revenue (US$, Mn) and Average Price (US$/KG) (2017-2022)
Table 88. Immune Adjuvant Production Capacity (KG) of Key Manufacturers in Global Market, 2020-2022 (KG)
Table 89. Global Immune Adjuvant Capacity Market Share of Key Manufacturers, 2020-2022
Table 90. Global Immune Adjuvant Production by Region, 2017-2022 (KG)
Table 91. Global Immune Adjuvant Production by Region, 2023-2028 (KG)
Table 92. Immune Adjuvant Market Opportunities & Trends in Global Market
Table 93. Immune Adjuvant Market Drivers in Global Market
Table 94. Immune Adjuvant Market Restraints in Global Market
Table 95. Immune Adjuvant Raw Materials
Table 96. Immune Adjuvant Raw Materials Suppliers in Global Market
Table 97. Typical Immune Adjuvant Downstream
Table 98. Immune Adjuvant Downstream Clients in Global Market
Table 99. Immune Adjuvant Distributors and Sales Agents in Global Market
LIST OF FIGURES
Figure 1. Immune Adjuvant Segment by Type
Figure 2. Immune Adjuvant Segment by Application
Figure 3. Global Immune Adjuvant Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Immune Adjuvant Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Immune Adjuvant Revenue, 2017-2028 (US$, Mn)
Figure 7. Immune Adjuvant Sales in Global Market: 2017-2028 (KG)
Figure 8. The Top 3 and 5 Players Market Share by Immune Adjuvant Revenue in 2021
Figure 9. By Type - Global Immune Adjuvant Sales Market Share, 2017-2028
Figure 10. By Type - Global Immune Adjuvant Revenue Market Share, 2017-2028
Figure 11. By Type - Global Immune Adjuvant Price (US$/KG), 2017-2028
Figure 12. By Application - Global Immune Adjuvant Sales Market Share, 2017-2028
Figure 13. By Application - Global Immune Adjuvant Revenue Market Share, 2017-2028
Figure 14. By Application - Global Immune Adjuvant Price (US$/KG), 2017-2028
Figure 15. By Region - Global Immune Adjuvant Sales Market Share, 2017-2028
Figure 16. By Region - Global Immune Adjuvant Revenue Market Share, 2017-2028
Figure 17. By Country - North America Immune Adjuvant Revenue Market Share, 2017-2028
Figure 18. By Country - North America Immune Adjuvant Sales Market Share, 2017-2028
Figure 19. US Immune Adjuvant Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Immune Adjuvant Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Immune Adjuvant Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Immune Adjuvant Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Immune Adjuvant Sales Market Share, 2017-2028
Figure 24. Germany Immune Adjuvant Revenue, (US$, Mn), 2017-2028
Figure 25. France Immune Adjuvant Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Immune Adjuvant Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Immune Adjuvant Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Immune Adjuvant Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Immune Adjuvant Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Immune Adjuvant Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Immune Adjuvant Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Immune Adjuvant Sales Market Share, 2017-2028
Figure 33. China Immune Adjuvant Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Immune Adjuvant Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Immune Adjuvant Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Immune Adjuvant Revenue, (US$, Mn), 2017-2028
Figure 37. India Immune Adjuvant Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Immune Adjuvant Revenue Market Share, 2017-2028
Figure 39. By Country - South America Immune Adjuvant Sales Market Share, 2017-2028
Figure 40. Brazil Immune Adjuvant Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Immune Adjuvant Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Immune Adjuvant Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Immune Adjuvant Sales Market Share, 2017-2028
Figure 44. Turkey Immune Adjuvant Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Immune Adjuvant Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Immune Adjuvant Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Immune Adjuvant Revenue, (US$, Mn), 2017-2028
Figure 48. Global Immune Adjuvant Production Capacity (KG), 2017-2028
Figure 49. The Percentage of Production Immune Adjuvant by Region, 2021 VS 2028
Figure 50. Immune Adjuvant Industry Value Chain
Figure 51. Marketing Channels
Figure 1. Immune Adjuvant Segment by Type
Figure 2. Immune Adjuvant Segment by Application
Figure 3. Global Immune Adjuvant Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Immune Adjuvant Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Immune Adjuvant Revenue, 2017-2028 (US$, Mn)
Figure 7. Immune Adjuvant Sales in Global Market: 2017-2028 (KG)
Figure 8. The Top 3 and 5 Players Market Share by Immune Adjuvant Revenue in 2021
Figure 9. By Type - Global Immune Adjuvant Sales Market Share, 2017-2028
Figure 10. By Type - Global Immune Adjuvant Revenue Market Share, 2017-2028
Figure 11. By Type - Global Immune Adjuvant Price (US$/KG), 2017-2028
Figure 12. By Application - Global Immune Adjuvant Sales Market Share, 2017-2028
Figure 13. By Application - Global Immune Adjuvant Revenue Market Share, 2017-2028
Figure 14. By Application - Global Immune Adjuvant Price (US$/KG), 2017-2028
Figure 15. By Region - Global Immune Adjuvant Sales Market Share, 2017-2028
Figure 16. By Region - Global Immune Adjuvant Revenue Market Share, 2017-2028
Figure 17. By Country - North America Immune Adjuvant Revenue Market Share, 2017-2028
Figure 18. By Country - North America Immune Adjuvant Sales Market Share, 2017-2028
Figure 19. US Immune Adjuvant Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Immune Adjuvant Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Immune Adjuvant Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Immune Adjuvant Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Immune Adjuvant Sales Market Share, 2017-2028
Figure 24. Germany Immune Adjuvant Revenue, (US$, Mn), 2017-2028
Figure 25. France Immune Adjuvant Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Immune Adjuvant Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Immune Adjuvant Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Immune Adjuvant Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Immune Adjuvant Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Immune Adjuvant Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Immune Adjuvant Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Immune Adjuvant Sales Market Share, 2017-2028
Figure 33. China Immune Adjuvant Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Immune Adjuvant Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Immune Adjuvant Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Immune Adjuvant Revenue, (US$, Mn), 2017-2028
Figure 37. India Immune Adjuvant Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Immune Adjuvant Revenue Market Share, 2017-2028
Figure 39. By Country - South America Immune Adjuvant Sales Market Share, 2017-2028
Figure 40. Brazil Immune Adjuvant Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Immune Adjuvant Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Immune Adjuvant Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Immune Adjuvant Sales Market Share, 2017-2028
Figure 44. Turkey Immune Adjuvant Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Immune Adjuvant Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Immune Adjuvant Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Immune Adjuvant Revenue, (US$, Mn), 2017-2028
Figure 48. Global Immune Adjuvant Production Capacity (KG), 2017-2028
Figure 49. The Percentage of Production Immune Adjuvant by Region, 2021 VS 2028
Figure 50. Immune Adjuvant Industry Value Chain
Figure 51. Marketing Channels
